1887

Abstract

is a particularly virulent pathogen when it causes bacteraemia and early diagnosis is essential to reduce morbidity and mortality. It is an aerobe and is thought by many to be almost exclusively isolated from the aerobic blood culture bottle in cases of bacteraemia. This study analysed 277 Gram-negative bacteraemic episodes over 1 year at a single institution in order to assess the predictive value of this finding. In 39 of 44 episodes of bacteraemia, the organism was isolated from the aerobic bottle only, which gave a sensitivity of 88.6 % for this ‘test’ and a specificity of 73.8 %. However, for all episodes of Gram-negative bacteraemia, the likelihood of a Gram-negative bacillus occurring in the aerobic bottle first being was only 39 %. The converse finding of a Gram-negative bacillus isolated first in the anaerobic bottle or from both bottles together was clinically helpful, having a negative predictive value of 97.2 % (i.e. that the organism was not ).

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45727-0
2004-11-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/53/11/JM531116.html?itemId=/content/journal/jmm/10.1099/jmm.0.45727-0&mimeType=html&fmt=ahah

References

  1. Chang, T. C. & Huang, A. H. ( 2000;). Rapid differentiation of fermentative from nonfermentative gram-negative bacilli in positive blood cultures by an impedance method. J Clin Microbiol 38, 3589–3594.
    [Google Scholar]
  2. Chatzinikolaou, I., Abi-Said, D., Bodey, G. P., Rolston, K. V., Tarrand, J. J. & Samonis, G. ( 2000;). Recent experience with Pseudomonas aeruginosa bacteraemia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med 160, 501–509.[CrossRef]
    [Google Scholar]
  3. Cherif, H., Kronvall, G., Bjorkholm, M. & Kalin, M. ( 2003;). Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Haematol J 4, 420–426.
    [Google Scholar]
  4. Cisneros, J. M. & Rodriguez-Bano, J. ( 2002;). Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 8, 687–693.[CrossRef]
    [Google Scholar]
  5. Collin, B. A., Leather, H. L., Wingard, J. R. & Ramphal, R. ( 2001;). Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 33, 947–953.[CrossRef]
    [Google Scholar]
  6. Doern, G. V., Vautour, R., Gaudet, M. & Levy, B. ( 1994;). Clinical impact of rapid in vitro susceptibility testing and bacterial identification . J Clin Microbiol 32, 1757–1762.
    [Google Scholar]
  7. Edgeworth, J. D., Treacher, D. F. & Eykyn, S. J. ( 1999;). A 25-year study of nosocomial bacteraemia in an adult intensive care unit. Crit Care Med 27, 1421–1428.[CrossRef]
    [Google Scholar]
  8. Garcia-Garmendia, J. L., Ortiz-Leyba, C., Garnacho-Montero, J., Jimenez-Jimenez, F. J., Perez-Paredes, C., Barrero-Almodovar, A. E. & Gili-Miner, M. ( 2001;). Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 33, 939–946.[CrossRef]
    [Google Scholar]
  9. Garrouste-Orgeas, M., Chevret, S., Mainardi, J. L., Timsit, J. F., Misset, B. & Carlet, J. ( 2000;). A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome. J Hosp Infect 44, 206–213.[CrossRef]
    [Google Scholar]
  10. Gransden, W. R., Leibovici, L., Eykyn, S. J., Pitlik, S. D., Samra, Z., Konisberger, H., Drucker, M. & Phillips, I. ( 1995;). Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteraemia. Clin Microbiol Infect 1, 119–123.[CrossRef]
    [Google Scholar]
  11. Hughes, W. T., Armstrong, D., Bodey, G. P. & 8 other authors ( 2002;). 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34, 730–751.[CrossRef]
    [Google Scholar]
  12. Jamal, W. Y., El-Din, K., Rotimi, V. O. & Chugh, T. D. ( 1999;). An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait. J Hosp Infect 43, 49–56.[CrossRef]
    [Google Scholar]
  13. Jugo, J., Kennedy, R., Crowe, M. J., Lamrock, G., McClurg, R. B., Rooney, P. J., Morris, T. C. & Johnston, P. G. ( 2002;). Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital. J Hosp Infect 50, 48–55.[CrossRef]
    [Google Scholar]
  14. Kang, C. I., Kim, S. H., Kim, H. B., Park, S. W., Choe, Y. J., Oh, M. D., Kim, E. C. & Choe, K. W. ( 2003;). Pseudomonas aeruginosa bacteraemia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 37, 745–751.[CrossRef]
    [Google Scholar]
  15. Leibovici, L., Paul, M., Poznanski, O., Drucker, M., Samra, Z., Konigsberger, H. & Pitlik, S. D. ( 1997;). Monotherapy versus β-lactam-aminoglycoside combination treatment for Gram-negative bacteraemia: a prospective, observational study. Antimicrob Agents Chemother 41, 1127–1133.
    [Google Scholar]
  16. Martino, R., Santamaria, A., Munoz, L., Pericas, R., Altes, A., Prats, G. & Sierra, J. ( 1999;). Bacteraemia by gram-negative bacilli in patients with haematological malignancies.Comparison of the clinical presentation and outcome of infections by enterobacteria and non-glucose-fermenting gram-negative bacilli. Acta Haematol 102, 7–11.[CrossRef]
    [Google Scholar]
  17. Maschmeyer, G. & Braveny, I. ( 2000;). Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 19, 915–925.[CrossRef]
    [Google Scholar]
  18. Ortiz, E. & Sande, M. A. ( 2000;). Routine use of anaerobic blood cultures: are they still indicated? Am J Med 108, 445–447.[CrossRef]
    [Google Scholar]
  19. Osman, S., Ward, S., Fraser, V. J. & Kollef, M. H. ( 2004;). Hospital mortality for patients with bacteraemia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 125, 607–616.
    [Google Scholar]
  20. Perez, C., Marchandin, H., Compan, B., Bonifacj, C., Despaux, E. & Mion, P. ( 1996;). Comparative evaluation of blood culture using the Vital automated system and the Becton-Dickinson Septi-Chek BHI-S biphasic and Sch bottles. Ann Biol Clin 54, 159–163.
    [Google Scholar]
  21. Pohlman, J. K., Kirkley, B. A., Easley, K. A. & Washington, J. A. ( 1995;). Controlled clinical trial of isolator and BACTEC 9240 Aerobic/F resin bottle for detection of bloodstream infections. J Clin Microbiol 33, 2525–2529.
    [Google Scholar]
  22. Rolston, K. V. I. & Tarrand, J. J. ( 1999;). Pseudomonas aeruginosa – still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer centre. Clin Infect Dis 29, 463–464.[CrossRef]
    [Google Scholar]
  23. Saito, T., Senda, K., Takakura, S. & 10 other authors ( 2003;). Anaerobic bacteraemia: the yield of positive anaerobic blood cultures: patient characteristics and potential risk factors. Clin Chem Lab Med 41, 293–297.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45727-0
Loading
/content/journal/jmm/10.1099/jmm.0.45727-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error